Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FIBRINOGEN RECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 279 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Santillan, MKO; Herring, J; Hoppensteadt, DA; Jeske, W; Herbert, JM; Fareed, J
      The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    2. Knight, LC
      Radiolabeled peptide ligands for imaging thrombi and emboli

      NUCLEAR MEDICINE AND BIOLOGY
    3. Moitessier, N; Dufour, S; Chretien, F; Thiery, JP; Maigret, B; Chapleur, Y
      Design, synthesis and preliminary biological evaluation of a focused combinatorial library of stereodiverse carbohydrate-scaffold-based peptidomimetics

      BIOORGANIC & MEDICINAL CHEMISTRY
    4. Hantgan, RR; Rocco, M; Nagaswami, C; Weisel, JW
      Binding of a fibrinogen mimetic stabilizes integrin alpha IIb beta 3's open conformation

      PROTEIN SCIENCE
    5. Dener, JM; Rice, KD; Newcomb, WS; Wang, VR; Young, WB; Gangloff, AR; Kuo, EYL; Cregar, L; Putnam, D; Wong, M
      Dibasic inhibitors of human mast cell tryptase. Part 3: Identification of a series of potent and selective inhibitors containing the benzamidine functionality

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    6. Smyth, MS; Rose, J; Mehrotra, MM; Heath, J; Ruhter, G; Schotten, T; Seroogy, J; Volkots, D; Pandey, A; Scarborough, RM
      Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 1: Design of potent and specific 3,9-diazaspiro[5.5]undecanes

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    7. Pandey, A; Seroogy, J; Volkots, D; Smyth, MS; Rose, J; Mehrotra, MM; Heath, J; Ruhter, G; Schotten, T; Scarborough, RM
      Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 2: Design of potent antagonists containing the 3-azaspiro[5.5]undec-9-yl template

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    8. Ervin, AL; Peerschke, EIB
      Platelet activation by sustained exposure to low-dose plasmin

      BLOOD COAGULATION & FIBRINOLYSIS
    9. Dabadie, M; Valli, N; Jacobin, MJE; Laroche-Traineau, J; Barat, JL; Ducassou, D; Nurden, AT; Clofent-Sanchez, G
      Characterisation, cloning and sequencing of a conformation-dependent monoclonal antibody to the alpha(IIb)beta(3) integrin: interest for use in thrombus detection

      PLATELETS
    10. Coller, BS
      Anti-GPIIb/IIIa drugs: Current strategies and future directions

      THROMBOSIS AND HAEMOSTASIS
    11. Savi, P; Zamboni, G; Rescanieres, O; Herbert, JM
      Studies on the binding of H-3-SR121566, an inhibitor of Gp IIb-IIIa activation

      THROMBOSIS AND HAEMOSTASIS
    12. Boudreaux, MK; Lipscomb, DL
      Clinical, biochemical, and molecular aspects of Glanzmann's thrombastheniain humans and dogs

      VETERINARY PATHOLOGY
    13. Plancon, S; Morel-Kopp, MC; Schaffner-Reckinger, E; Chen, P; Kieffer, N
      Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alpha IIb or beta 3 allows the expression of a fully functional integrin alpha IIIbbeta 3: effect of beta 3(GFP) on alpha IIb beta 3 ligand binding

      BIOCHEMICAL JOURNAL
    14. Darius, H
      Oral glycoprotein Ilb/IIa antagonists for unstable angina - Is there stilla chance for the oral substances?

      THROMBOSIS RESEARCH
    15. Dickfeld, T; Ruf, A; Pogatsa-Murray, G; Muller, I; Engelmann, B; Taubitz, W; Fischer, J; Meier, O; Gawaz, M
      Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists

      THROMBOSIS RESEARCH
    16. Peterlin-Masic, L; Kikelj, D
      Arginine mimetics

      TETRAHEDRON
    17. Matsuno, H; Kozawa, O; Niwa, M; Abe, A; Takiguchi, Y; Uematsu, T
      Characterization of simple and reproducible vascular stenosis model in hypercholesterolemic hamsters

      LIPIDS
    18. Thibault, G; Tardif, P; Lapalme, G
      Comparative specificity of platelet alpha(IIb)beta(3) integrin antagonists

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    19. Sulyok, GAG; Gibson, C; Goodman, SL; Holzemann, G; Wiesner, M; Kessler, H
      Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective alpha v beta 3 integrin antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    20. Josefsson, E; Hartford, O; O'Brien, L; Patti, JM; Foster, T
      Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant

      JOURNAL OF INFECTIOUS DISEASES
    21. Bravo, P; Bruche, L; Pesenti, C; Viani, F; Volonterio, A; Zanda, M
      Solution and solid-phase synthesis of trifluoromethyl peptides and mimetics

      JOURNAL OF FLUORINE CHEMISTRY
    22. Siboo, IR; Cheung, AL; Bayer, AS; Sullam, PM
      Clumping factor A mediates binding of Staphylococcus aureus to human platelets

      INFECTION AND IMMUNITY
    23. Que, YA; Francois, P; Haefliger, JA; Entenza, JM; Vaudaux, P; Moreillon, P
      Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis

      INFECTION AND IMMUNITY
    24. Patrono, C; Coller, B; Dalen, JE; FitzGerald, GA; Fuster, V; Gent, M; Hirsh, J; Roth, G
      Platelet-active drugs - The relationships among dose, effectiveness, and side effects

      CHEST
    25. Kitamura, S; Fukushi, H; Miyawaki, T; Kawamura, M; Terashita, Z; Sugihara, H; Naka, T
      Novel non-peptide GPIIb/IIIa antagonists: Synthesis and biological activities of 2-[4-[2-(4-amidinobenzoylamino)-2-(substituted)acetyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl]acetic acids

      CHEMICAL & PHARMACEUTICAL BULLETIN
    26. Kitamura, S; Fukushi, H; Miyawaki, T; Kawamura, M; Terashita, Z; Naka, T
      Orally active GPIIb/IIIa antagonists: Synthesis and biological activities of masked amidines as prodrugs of 2-[(3S)-4-[(2S)-2-(4-amidinobenzoylanlino)-3-(4-methoxyphenyl)propanoyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl]acetic acid

      CHEMICAL & PHARMACEUTICAL BULLETIN
    27. Rozalski, M; Boncler, M; Golanski, J; Watala, C
      Effects of fibrinogen receptor antagonists GR144053F and aurintricarboxylic acid on platelet activation and degranulation

      BIOCHEMICAL PHARMACOLOGY
    28. Basso, A; Pegg, N; Evans, B; Bradley, M
      Solid-phase synthesis of amidine-based GP IIb-IIIa antagonists on dendrimer resin beads

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    29. Dal Pozzo, A; Fagnoni, N; Bergonzi, R; Vanini, L; de Castiglione, R; Aglio, C; Colli, S
      Synthesis and anti-aggregatory activity of linear retro-inverso RGD peptides

      JOURNAL OF PEPTIDE RESEARCH
    30. Liu, FQ; Craft, RM; Morris, SA; Carroll, RC
      Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    31. Krys'ko, AA; Kabanov, VM; Polishchuk, PG; Chugunov, BM; Pavlovskii, VI; Andronati, SA; Mazepa, AV; Kabanova, TA; Karaseva, TL
      Synthesis and antiaggregation activity of a new RGDF peptidomimetic

      RUSSIAN JOURNAL OF GENERAL CHEMISTRY
    32. Leadley, RJ; Chi, LG; Rebello, SS; Gagnon, A
      Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    33. Egbertson, MS; Bednar, B; Askew, BC; Bednar, RA; Brashear, K; Breslin, MJ; Duggan, ME; Fisher, TE; Halczenko, W; Hutchinson, JH; Ihle, N; Prugh, JD; Wai, JS; Gould, RJ; Hartman, GD
      Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    34. Natarajan, P; May, JA; Sanderson, HM; Zabe, M; Spangenberg, P; Heptinstall, S
      Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function

      PLATELETS
    35. Osterkamp, F; Ziemer, B; Koert, U; Wiesner, M; Raddatz, P; Goodman, SL
      Synthesis and biological evaluation of integrin antagonists-containing trans- and cis-2,5-disubstituted THF rings

      CHEMISTRY-A EUROPEAN JOURNAL
    36. Wang, W; Borchardt, RT; Wang, B
      Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists

      CURRENT MEDICINAL CHEMISTRY
    37. Minoux, H; Chipot, C; Brown, D; Maigret, B
      Structural analysis of the KGD sequence loop of barbourin, an alpha(IIb)beta(3)-specific disintegrin

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    38. Bottiger, C; Kastrati, A; Koch, W; Mehilli, J; Seidl, H; Schomig, K; von Beckerath, N; Schomig, A
      HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction

      THROMBOSIS AND HAEMOSTASIS
    39. Drewe, J; Narjes, H; Heinzel, G; Brickl, RS; Rohr, A; Beglinger, C
      Absorption of lefradafiban from different sites of the gastrointestinal tract

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    40. Habazettl, H; Hanusch, P; Kupatt, C
      Effects of endothelium/leukocytes/platelet interaction on myocardial ischemia - reperfusion injury

      ZEITSCHRIFT FUR KARDIOLOGIE
    41. Tung, HS; Guss, B; Hellman, U; Persson, L; Rubin, K; Ryden, C
      A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family

      BIOCHEMICAL JOURNAL
    42. Wang, W; Camenisch, G; Sane, DC; Zhang, HJ; Hugger, E; Wheeler, GL; Borchardt, RT; Wang, BH
      A coumarin-based prodrug strategy to improve the oral absorption of RGD peptidomimetics

      JOURNAL OF CONTROLLED RELEASE
    43. Bate, AL; Ma, JKC; Ford, TRP
      Detection of bacterial virulence genes associated with infective endocarditis in infected root canals

      INTERNATIONAL ENDODONTIC JOURNAL
    44. Smallheer, JM; Olson, RE; Wexler, RR
      Antiplatelet therapies

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
    45. Kinlough-Rathbone, RL; Perry, DW; Rand, ML; Packham, MA
      Responses to aggregating agents after cleavage of GPIb of human platelets by the O-sialoglycoprotein endoprotease from Pasteurella haemolytica - Potential surrogates for Bernard-Soulier platelets?

      THROMBOSIS RESEARCH
    46. Duggan, ME; Duong, LT; Fisher, JE; Hamill, TG; Hoffman, WF; Huff, JR; Ihle, NC; Leu, CT; Nagy, RM; Perkins, JJ; Rodan, SB; Wesolowski, G; Whitman, DB; Zartman, AE; Rodan, GA; Hartman, GD
      Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist

      JOURNAL OF MEDICINAL CHEMISTRY
    47. Scarborough, RM; Gretler, DD
      Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: Novel parenteral and potential oral antithrombotic agents

      JOURNAL OF MEDICINAL CHEMISTRY
    48. Miller, WH; Alberts, DP; Bhatnagar, PK; Bondinell, WE; Callahan, JF; Calvo, RR; Cousins, RD; Erhard, KF; Heerding, DA; Keenan, RM; Kwon, C; Manley, PJ; Newlander, KA; Ross, ST; Samanen, JM; Uzinskas, IN; Venslavsky, JW; Yuan, CCK; Haltiwanger, RC; Gowen, M; Hwang, SM; James, IE; Lark, MW; Rieman, DJ; Stroup, GB; Azzarano, LM; Salyers, KL; Smith, BR; Ward, KW; Johanson, KO; Huffman, WF
      Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic

      JOURNAL OF MEDICINAL CHEMISTRY
    49. Batt, DG; Petraitis, JJ; Houghton, GC; Modi, DP; Cain, GA; Corjay, MH; Mousa, SA; Bouchard, PJ; Forsythe, MS; Harlow, PP; Barbera, FA; Spitz, SM; Wexler, RR; Jadhav, PK
      Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3)

      JOURNAL OF MEDICINAL CHEMISTRY
    50. Francois, P; Schrenzel, J; Stoerman-Chopard, C; Favre, H; Herrmann, M; Foster, TJ; Lew, DP; Vaudaux, P
      Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    51. Verstraete, M
      Synthetic inhibitors of platelet glycoprotein IIb/IIIa in clinical development

      CIRCULATION
    52. Liao, Y; Hendrata, S; Bae, SY; Wang, BH
      The effect of phenyl substituents on the release rates of esterase-sensitive coumarin-based prodrugs

      CHEMICAL & PHARMACEUTICAL BULLETIN
    53. Tao, JM; Arias-Salgado, EG; Gonzalez-Manchon, C; Diaz-Cremades, J; Ayuso, MS; Parrilla, R
      A novel (288delC) mutation in exon 2 of GPIIb associated with type I Glanzmann's thrombasthenia

      BRITISH JOURNAL OF HAEMATOLOGY
    54. Mondoro, TH; White, MM; Jennings, LK
      Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization

      BLOOD
    55. Stavrakoudis, A; Bizos, G; Eleftheriadis, D; Kouki, A; Panou-Pomonis, E; Sakarellos-Daitsiotis, M; Sakarellos, C; Tsoukatos, D; Tsikaris, V
      A three-residue cyclic scaffold of non-RGD containing peptide analogues asplatelet aggregation inhibitors: Design, synthesis, and structure-functionrelationships

      BIOPOLYMERS
    56. Payrastre, B; Missy, K; Trumel, C; Bodin, S; Plantavid, M; Chap, H
      The integrin alpha IIb/beta 3 in human platelet signal transduction

      BIOCHEMICAL PHARMACOLOGY
    57. Curley, GP; Blum, H; Humphries, MJ
      Integrin antagonists

      CELLULAR AND MOLECULAR LIFE SCIENCES
    58. Bogdanowich-Knipp, SJ; Jois, DSS; Siahaan, TJ
      The effect of conformation on the solution stability of linear vs. cyclic RGD peptides

      JOURNAL OF PEPTIDE RESEARCH
    59. Bogdanowich-Knipp, SJ; Chakrabarti, S; Williams, TD; Dillmall, RK; Siahaan, TJ
      Solution stability of linear vs. cyclic RGD peptides

      JOURNAL OF PEPTIDE RESEARCH
    60. Wang, Y; Goh, SY; Kuczera, K
      Molecular dynamics study of disulfide bond influence on properties of an RGD peptide

      JOURNAL OF PEPTIDE RESEARCH
    61. Flock, JI
      Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections

      MOLECULAR MEDICINE TODAY
    62. Hartford, O; McDevitt, D; Foster, TJ
      Matrix-binding proteins of Staphylococcus aureus: functional analysis of mutant and hybrid molecules

      MICROBIOLOGY-UK
    63. Wang, JS; Cheng, LJ
      Effect of strenuous, acute exercise on alpha(2)-adrenergic agonist-potentiated platelet activation

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    64. Hartman, GD; Duggan, ME; Hoffman, WF; Meissner, RJ; Perkins, JJ; Zartman, AE; Naylor-Olsen, AM; Cook, JJ; Glass, JD; Lynch, RJ; Zhang, GX; Gould, RJ
      Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors.

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    65. White, JG; Krumwiede, MD; Escolar, G
      EDTA induced changes in platelet structure and function: influence on particle uptake

      PLATELETS
    66. Conran, N; Hemming, FW
      Phorbol ester induces a transient increase in alpha(5)beta(1)-mediated adhesion of the megakaryoblastic cell line CHRF 288-11

      PLATELETS
    67. Scarborough, RM
      Structure-activity relationships of beta-amino acid-containing integrin antagonists

      CURRENT MEDICINAL CHEMISTRY
    68. Montero-Lastres, A; Fraiz, N; Laguna, R; Cano, E; Estevez, I; Ravina, E
      Pyridazines XVIII. 6-aryl-3(2H)-pyridazinones inhibit calcium influx in stimulated platelets

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    69. Kamm, W; Raddatz, P; Gante, J; Kissel, T
      Prodrug approach for alpha(IIb)beta(3)-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): Comparison of in vitro and in vivo data

      PHARMACEUTICAL RESEARCH
    70. Hudson, MC; Ramp, WK; Frankenburg, KP
      Staphylococcus aureus adhesion to bone matrix and bone-associated biomaterials

      FEMS MICROBIOLOGY LETTERS
    71. Wann, ER; Dassy, B; Fournier, JM; Foster, TJ
      Genetic analysis of the cap5 locus of Staphylococcus aureus

      FEMS MICROBIOLOGY LETTERS
    72. Hamill, TG; Hutchinson, JH; Brashear, KM; Hartman, GD
      Non-peptide fibrinogen receptor antagonists. 4(1). The synthesis of [H-3]L-756,568.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    73. Braun, MP; Dean, DC; Melillo, DG
      Suzuki Cross-Coupling for the incorporation of labeled methyl groups onto aryl halides. A synthesis of [C-14]tosyl chloride and its use in the synthesis of [C-14]L-738,167.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    74. Berlinck, RGS
      Natural guanidine derivatives

      NATURAL PRODUCT REPORTS
    75. Bernat, A; Hoffmann, P; Savi, P; Lale, A; Herbert, JM
      Interspecies comparison of the antiplatelet, antithrombotic, and hemorrhagic effects of SR 121566A, a novel nonpeptide GP IIb IIIa antagonist

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    76. Vickers, S; Theoharides, AD; Arison, B; Balani, SK; Cui, D; Duncan, CA; Ellis, JD; Gorham, LM; Polsky, SL; Prueksaritanont, T; Ramjit, HG; Slaughter, DE; Vyas, KP
      In vitro and in vivo studies on the metabolism of tirofiban

      DRUG METABOLISM AND DISPOSITION
    77. Wu, H; Peng, L; Li, J; Wu, W; Hou, Q; Liu, H; Wang, M
      Reversible exposure of human platelet fibrinogen receptors by antiplatelettetraspanin monoclonal antibodies via induction of a conformational changein membrane glycoprotein IIb/IIIa complex

      THROMBOSIS RESEARCH
    78. Ito, T; Matsuno, H; Kozawa, O; Niwa, M; Sakai, N; Uematsu, T
      Comparison of the antithrombotic effects and bleeding risk of fractionatedaurin tricarboxylic acid and the GPIIb IIIa antagonist GR144053 in a hamster model of stenosis

      THROMBOSIS RESEARCH
    79. Osterkamp, F; Wehlan, H; Koert, U; Wiesner, M; Raddatz, P; Goodman, SL
      Synthesis and biological evaluation of dianhydrohexitol integrin antagonists

      TETRAHEDRON
    80. Hoekstra, WJ; Maryanoff, BE; Damiano, BP; Andrade-Gordon, P; Cohen, JH; Costanzo, MJ; Haertlein, BJ; Hecker, LR; Hulshizer, BL; Kauffman, JA; Keane, P; McComsey, DF; Mitchell, JA; Scott, L; Shah, RD; Yabut, SC
      Potent, orally active GPIIb/IIIa antagonists containing a nipecotic acid subunit. Structure-activity studies leading to the discovery of RWJ-53308

      JOURNAL OF MEDICINAL CHEMISTRY
    81. Fisher, MJ; Arfstan, AE; Giese, U; Gunn, BP; Harms, CS; Khau, V; Kinnick, MD; Lindstrom, TD; Martinelli, MJ; Mest, HJ; Mohr, M; Morin, JM; Mullaney, JT; Nunes, A; Paal, M; Rapp, A; Ruhter, G; Ruterbories, KJ; Sall, DJ; Scarborough, RM; Schotten, T; Sommer, B; Stenzel, W; Towner, RD; Um, SL; Utterback, BG; Vasileff, RT; Voelkers, S; Wyss, VL; Jakubowski, JA
      Fused bicyclic Gly-Asp beta-turn mimics with specific affinity for GPIIb-IIIa

      JOURNAL OF MEDICINAL CHEMISTRY
    82. Egbertson, MS; Cook, JJ; Bednar, B; Prugh, JD; Bednar, RA; Gaul, SL; Gould, RJ; Hartman, GD; Homnick, CF; Holahan, MA; Libby, LA; Lynch, JJ; Lynch, RJ; Sitko, GR; Stranieri, MT; Vassallo, LM
      Non-peptide GPIIb IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation

      JOURNAL OF MEDICINAL CHEMISTRY
    83. Dziewanowska, K; Patti, JM; Deobald, CF; Bayles, KW; Trumble, WR; Bohach, GA
      Fibronectin binding protein and host cell tyrosine kinase are required forinternalization of Staphylococcus aureus by epithelial cells

      INFECTION AND IMMUNITY
    84. Dooley, M; Goa, KL
      Sibrafiban

      DRUGS
    85. Quinn, M; Deering, A; Stewart, M; Cox, D; Foley, B; Fitzgerald, D
      Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies - Discriminating abciximab and small molecular weight antagonists

      CIRCULATION
    86. Scarborough, RM; Kleiman, NS; Phillips, DR
      Platelet glycoprotein IIb/IIIa antagonists - What are the relevant issues concerning their pharmacology and clinical use?

      CIRCULATION
    87. Ono, S; Inoue, Y; Yoshida, T; Ashimori, A; Kosaka, K; Imada, T; Fukaya, C; Nakamura, N
      Preparation and pharmacological evaluation of novel glycoprotein (Gp) IIb/IIIa antagonists. 1. The selection of naphthalene derivatives

      CHEMICAL & PHARMACEUTICAL BULLETIN
    88. Ono, S; Yoshida, T; Maeda, K; Kosaka, K; Inoue, Y; Imada, T; Fukaya, C; Nakamura, N
      Preparation and pharmacological evaluation of novel glycoprotein (Gp) IIlb/IIIa aneagonists. 2. Condensed heterocyclic derivatives

      CHEMICAL & PHARMACEUTICAL BULLETIN
    89. Wang, BH; Wang, W; Camenisch, GP; Elmo, J; Zhang, HJ; Borchardt, RT
      Synthesis and evaluation of novel coumarin-based esterase-sensitive cyclicprodrugs of peptidomimetic RGD analogs with improved membrane permeability

      CHEMICAL & PHARMACEUTICAL BULLETIN
    90. Williams, RC; Miyawa, JH; Boucher, RJ; Brockson, RW
      Optimization and validation of chiral high-performance liquid chromatographic method for analysis of a fibrinogen (gpIIb/IIIa) receptor antagonist

      JOURNAL OF CHROMATOGRAPHY A
    91. PONS JF; FAUCHERE JL; LAMATY F; MOLLA A; LAZARO R
      A CONSTRAINED DIKETOPIPERAZINE AS A NEW SCAFFOLD FOR THE SYNTHESIS OFPEPTIDOMIMETICS

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    92. HUANG TF
      WHAT HAVE SNAKES TAUGHT US ABOUT INTEGRINS

      Cellular and molecular life sciences
    93. Josefsson, E; McCrea, KW; Ni Eidhin, D; O'Connell, D; Cox, J; Hook, M; Foster, TJ
      Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus

      MICROBIOLOGY-UK
    94. HARKER LA
      THERAPEUTIC INHIBITION OF PLATELET-FUNCTION IN STROKE

      Cerebrovascular diseases
    95. BOXUS T; TOUILLAUX R; DIVE G; MARCHANDBRYNAERT J
      SYNTHESIS AND EVALUATION OF RGD PEPTIDOMIMETICS AIMED AT SURFACE BIODERIVATIZATION OF POLYMER SUBSTRATES

      Bioorganic & medicinal chemistry
    96. HAYASHI Y; KATADA J; SATO Y; IGARASHI K; TAKIGUCHI Y; HARADA T; MURAMATSU M; YASUDA E; UNO I
      DISCOVERY AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF A NOVEL AND SPECIFIC PEPTIDE MOTIF, PRO-X-X-X-ASP-X, AS A PLATELET FIBRINOGEN RECEPTOR ANTAGONIST

      Bioorganic & medicinal chemistry
    97. Robarge, KD; Dina, MS; Somers, TC; Lee, A; Rawson, TE; Olivero, AG; Tischler, MH; Webb, RR; Weese, KJ; Aliagas, I; Blackburn, BK
      Preparation and biological activity of novel tricyclic GPIIb/IIIa antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY
    98. Keenan, RM; Miller, WH; Lago, MA; Ali, FE; Bondinell, WE; Callahan, JF; Calvo, RR; Cousins, RD; Hwang, SM; Jakas, DR; Ku, TW; Kwon, C; Nguyen, TT; Reader, VA; Rieman, DJ; Ross, ST; Takata, DT; Uzinskas, IN; Yuan, CCK; Smith, BR
      Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    99. MAY JA; RATAN H; GLENN JR; LOSCHE W; SPANGENBERG P; HEPTINSTALL S
      GPIIB-IIIA ANTAGONISTS CAUSE RAPID DISAGGREGATION OF PLATELETS PRETREATED WITH CYTOCHALASIN-D - EVIDENCE THAT THE STABILITY OF PLATELET AGGREGATES DEPENDS ON NORMAL CYTOSKELETAL ASSEMBLY

      Platelets
    100. SANDERSON HM; FOX SC; ROBBINS RA; LOSCHE W; SPANGENBERG P; HEPTINSTALL S
      ROLE OF GPIIB-IIIA IN PLATELET-MONOCYTE AND PLATELET-NEUTROPHIL CONJUGATE FORMATION IN WHOLE-BLOOD

      Platelets


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 13:12:19